Fig. 2From: Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)Heatmaps summarizing changes in gene expression over time in two major molecular functional groups in NET responders and non-responders. Samples are ordered from left to right by patient identification for each time point. Red and blue represent relative high and low log2 gene expression values, respectivelyBack to article page